In conclusion, there is an emerging need in pathology to enhance and standardize the evaluation of companion biomarkers such as PD-L1 by using validated digital pathology tools to not only remotely train pathologists to provide a reliable CPS for HNSCC, but to also leverage computer-assisted tools to more accurately do so. This evidence concerns the gene CD274 and head and neck squamous cell carcinoma.